Get the Stockscreener App
7.82
1.43%
0.11
After Hours:
7.82
Goodrx Holdings Inc stock is traded at $7.82, with a volume of 673.54K.
It is up +1.43% in the last 24 hours and up +8.46% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$7.71
Open:
$7.74
24h Volume:
673.54K
Relative Volume:
0.49
Market Cap:
$2.99B
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
310.32
EPS:
0.0252
Net Cash Flow:
$64.06M
1W Performance:
-1.01%
1M Performance:
+8.46%
6M Performance:
+5.82%
1Y Performance:
+26.54%
1-Day Range:
$7.62
$7.89
1-Week Range:
$7.62
$8.1599
52-Week Range:
$4.135
$9.2599
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
(GDRX) Investment Analysis and Advice - Stock Traders Daily
Spectrum Equity sells shares in GoodRx Holdings worth over $83k - Investing.com
Equity Vii L.P. Spectrum Sells 10,677 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Acquired by Picton Mahoney Asset Management - MarketBeat
GoodRx (NASDAQ:GDRX) Shares Down 2.6% - MarketBeat
Legato Capital Management LLC Takes $805,000 Position in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
66,615 Shares in GoodRx Holdings, Inc. (NASDAQ:GDRX) Bought by Liontrust Investment Partners LLP - MarketBeat
GoodRx (NASDAQ:GDRX) Trading Up 2.2% - MarketBeat
High Growth Tech Stocks To Watch In The United States - Simply Wall St
NASDAQ: GDRX Lawsuit Update: Investors Who Lost Money With GoodRx Holdings, Inc. (NASDAQ: GDRX) Shares Should Contact the Shareholders Foundation - Newswire
GoodRx (NASDAQ:GDRX) Trading Down 3.4% - MarketBeat
GoodRx to Participate in Upcoming Investor Conferences - Business Wire
GoodRx (GDRX) – Research Analysts’ Recent Ratings Changes - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Short Interest Update - MarketBeat
GoodRx (NASDAQ:GDRX) Shares Gap Up to $7.17 - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Sees Large Decline in Short Interest - Defense World
GoodRx (NASDAQ:GDRX) Rating Reiterated by Royal Bank of Canada - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Purchased by California State Teachers Retirement System - Defense World
GoodRx (NASDAQ:GDRX) Stock Rating Reaffirmed by Royal Bank of Canada - MarketBeat
GoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) - Benzinga
Shareholders that lost money on GoodRx Holdings, Inc.(GDRX) should contact The Gross Law Firm about pending Class Action - Longview News-Journal
GoodRx Holdings executive sells $534k in company stock - Investing.com India
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx - Longview News-Journal
Insider Sale: Chief Accounting Officer Romin Nabiey Sells 79,000 Shares of GoodRx Holdings Inc (GDRX) - GuruFocus.com
Insider Sale: Chief Accounting Officer Romin Nabiey Sells 79,000 Shares of GoodRx Holdings Inc ... By GuruFocus - Investing.com Canada
GoodRx Holdings executive sells $534k in company stock - Investing.com
GoodRx Holdings executive sells $534k in company stock By Investing.com - Investing.com Canada
GoodRx Holdings executive sells $534k in company stock By Investing.com - Investing.com UK
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm - Longview News-Journal
GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit - Longview News-Journal
FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against GoodRx Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Longview News-Journal
GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges - MSN
GoodRx shares hold Buy rating with steady price target by TD Cowen - Investing.com
GoodRx (NASDAQ:GDRX) Stock Price Down 5.4% on Analyst Downgrade - MarketBeat
GoodRx (NASDAQ:GDRX) PT Lowered to $8.50 at UBS Group - Defense World
Citigroup Trims GoodRx (NASDAQ:GDRX) Target Price to $10.00 - Defense World
(GDRX) Trading Signals - Stock Traders Daily
GoodRx (NASDAQ:GDRX) Shares Gap Up to $7.01 - Defense World
GoodRx (NASDAQ:GDRX) Shares Gap Down to $8.61 - Defense World
GoodRx Holdings Second Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
GoodRx (NASDAQ:GDRX) Price Target Cut to $10.00 - MarketBeat
GoodRx (NASDAQ:GDRX) Upgraded to Strong-Buy by Raymond James - MarketBeat
GoodRx (NASDAQ:GDRX) Shares Gap Up to $7.01 - MarketBeat
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2024 Earnings Call Transcript - Insider Monkey
Raymond James Upgrades GoodRx (NASDAQ:GDRX) to “Strong-Buy” - Defense World
GDRXGoodRx Holdings, Inc. Latest Stock News & Market Updates - StockTitan
GoodRx (NASDAQ:GDRX) Shares Gap Down to $8.61 - MarketBeat
GoodRx Holdings, Inc. (GDRX) Q2 2024 Earnings Call Transcript - Seeking Alpha
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2024 Earnings Call Transcript - MSN
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.30%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):